Ernexa Therapeutics Inc (ERNA): Next-Year EPS Estimate 89.68%
As of 2026-11-07, Ernexa Therapeutics Inc (ERNA) has a next-year EPS growth estimate of 89.68%. Featured in 3 EPS revision reports, most recently on 2026-05-19.
Analyst estimates for ERNA have remained steady in the most recent observable window, with next-year EPS growth projected at 89.68%. Current-year growth stands at 67.76%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 89.68%
- EPS growth this year
- 67.76%
- EPS next quarter (est)
- -$3.84
- Last price
- $1.88
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-11-07 | 89.68% | 67.76% | -$3.84 | $1.88 |
| 2026-11-06 | 89.68% | 67.76% | -$3.84 | $1.88 |
| 2026-11-05 | 89.68% | 67.76% | -$3.84 | $1.83 |
| 2026-11-04 | 89.68% | 67.76% | -$3.84 | $1.99 |
| 2026-11-03 | 89.68% | 67.76% | -$3.84 | $2.02 |
| 2026-11-02 | 89.68% | 67.76% | -$3.84 | $1.95 |
| 2026-10-31 | 89.68% | 67.76% | -$3.84 | $1.97 |
| 2026-10-30 | 89.68% | 67.76% | -$3.84 | $1.97 |
| 2026-10-29 | 89.68% | 67.76% | -$3.84 | $2.11 |
| 2026-10-28 | 89.68% | 67.76% | -$3.84 | $1.98 |
| 2026-10-27 | 89.68% | 67.76% | -$3.84 | $1.99 |
| 2026-10-26 | 89.68% | 67.76% | -$3.84 | $1.94 |
| 2026-10-23 | 89.68% | 67.76% | -$3.84 | $2.07 |
| 2026-10-22 | 89.68% | 67.76% | -$3.84 | $2.08 |
| 2026-10-21 | 89.68% | 67.76% | -$3.84 | $2.11 |
| 2026-10-20 | 89.68% | 67.76% | -$3.84 | $2.24 |
| 2026-10-19 | 89.68% | 67.76% | -$3.84 | $1.98 |
| 2026-10-16 | 89.68% | 67.76% | -$3.84 | $2.09 |
| 2026-10-15 | 89.68% | 67.76% | -$3.84 | $2.17 |
| 2026-10-14 | 89.68% | 67.76% | -$3.84 | $2.11 |
| 2026-10-13 | 89.68% | 67.76% | -$3.84 | $2.21 |
| 2026-10-12 | 89.68% | 67.76% | -$3.84 | $2.21 |
| 2026-10-11 | 89.68% | 67.76% | -$3.84 | $2.40 |
| 2026-10-10 | 89.68% | 67.76% | -$3.84 | $2.40 |
| 2026-10-09 | 89.68% | 67.76% | -$3.84 | $2.40 |
| 2026-10-08 | 89.68% | 67.76% | -$3.84 | $2.49 |
| 2026-10-07 | 89.68% | 67.76% | -$3.84 | $2.39 |
| 2026-10-06 | 89.68% | 67.76% | -$3.84 | $2.23 |
| 2026-10-05 | 89.68% | 67.76% | -$3.84 | $2.70 |
| 2026-10-04 | 89.68% | 67.76% | -$3.84 | $2.96 |
Reports Featuring ERNA
Screen Performance
Aggregate stats across all 2145 tickers our top-EPS-revision screen has flagged over the past 225 days.
- Median return since detection
- -2.9%
- % of tickers in the green
- 43%
- Median return on winners
- +22.8%
- Large revisions captured
- 2246
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Ernexa Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-11-07, Ernexa Therapeutics Inc (ERNA) has a next-year EPS growth estimate of 89.68%, based on analyst consensus.
What sector and industry does Ernexa Therapeutics Inc belong to?▾
Ernexa Therapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ERNA appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Ernexa Therapeutics Inc (ERNA) appears here because it was detected by our daily top-EPS-revision-performer screen.